 Long-term followup results expectant management stage prostatic cancer total patients stage adenocarcinoma prostate years mean years patients underwent second staging transurethral resection prostate Progressive disease patients residual foci cancer second transurethral resection treatment patients second transurethral resection residual cancer progressive disease April December patients transrectal ultrasonography guided biopsies patients progressive disease Progressive disease patients Thus patients progressive disease long-term followup interval diagnosis stage disease detection progression months years mean years patients underwent definitive treatment progressive disease underwent palliative therapy therapy due poor physical condition patients definitive therapy alive evidence disease unrelated causes evidence disease alive stage disease data patients second staging transurethral resection prostate residual cancer high probability progressive disease negative findings second staging transurethral resection possibility disease progression Expectant management stage disease regular long-term followup mandatory